Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Columbus, Ohio 43214


Purpose:

The overall goal of this study is to determine the efficacy of tocotrienol (TCT), a natural form of vitamin E, in preventing or reducing scar formation in human skin wounds as well as the basal levels of TCT in normal human skin and adipose tissue.


Study summary:

Scar formation is the physiological and inevitable end point of mammalian wound healing and there is substantial evidence that inflammation is an essential prerequisite for scarring. Although scar tissue restores the normal skin barrier, the new tissue is inferior in structural, aesthetic, and functional respects. The mammalian wound healing response may have originated during the time of high susceptibility to infection. Therefore, we may have developed speed optimized wound healing where a multiple redundant compensating rapid inflammatory response allows the wound to heal quickly without infection. The scar is then the price mammals have to pay for evolutionary survival after being wounded. Tocotrienol may be an effective tool to prevent or reduce normal, hypertrophic, or keloid scarring by mediating the inflammatory response. Tocotrienol is a safe and convenient treatment that could be used by mouth or topically. There has never been a study on the effectiveness of tocotrienol in preventing or reducing scar formation.


Criteria:

Inclusion Criteria: - 18 years of age or older. - Non- smoker - No current medications that alter liver metabolism (e.g., Phenobarbital, HmG co-A inhibitors, etc.) - Non- pregnant or non-breastfeeding - No current use of dietary supplements containing vitamin-E - Not actively abusing drugs or alcohol Exclusion Criteria: - Under 18 years of age - Prisoners - Current smoker - Pregnant or breastfeeding - HIV diagnosis - Viral hepatitis diagnosis - Immunosuppressive therapy - Actively abusing drugs or alcohol - Current use of dietary supplements containing vitamin-E


NCT ID:

NCT00700791


Primary Contact:

Principal Investigator
Chandan K Sen, PhD
Ohio State University


Backup Contact:

N/A


Location Contact:

Columbus, Ohio 43214
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.